AUD 0.07
(-2.99%)
Year | Inventory | Inventory Growth |
---|---|---|
2024 | 1.58 Million AUD | 88.65% |
2023 | 839.96 Thousand AUD | 157.2% |
2022 | 326.57 Thousand AUD | 11.64% |
2021 | 292.53 Thousand AUD | -63.33% |
2020 | 797.69 Thousand AUD | 46.54% |
2019 | 544.34 Thousand AUD | 9.33% |
2018 | 497.9 Thousand AUD | -78.69% |
2017 | 2.33 Million AUD | 13.62% |
2016 | 2.05 Million AUD | 79.37% |
2015 | 1.14 Million AUD | 102.54% |
2014 | 565.95 Thousand AUD | 94.02% |
2013 | 291.69 Thousand AUD | 36.05% |
2012 | 214.4 Thousand AUD | -26.3% |
2011 | 290.9 Thousand AUD | 1189.05% |
2010 | 22.56 Thousand AUD | -76.58% |
2009 | 96.37 Thousand AUD | -40.24% |
2008 | 161.26 Thousand AUD | -80.43% |
2007 | 824.04 Thousand AUD | -48.16% |
2006 | 1.58 Million AUD | 23.33% |
2005 | 1.28 Million AUD | 60.66% |
2004 | 802.3 Thousand AUD | 0.0% |
2002 | 429 Thousand AUD | 36.19% |
2001 | 315 Thousand AUD | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 FY | 1.58 Million AUD | 88.65% |
2024 Q2 | 1.61 Million AUD | 0.0% |
2024 Q4 | 1.58 Million AUD | 0.0% |
2023 FY | 839.96 Thousand AUD | 157.2% |
2023 Q2 | 495.64 Thousand AUD | 0.0% |
2023 Q4 | 839.96 Thousand AUD | 0.0% |
2022 Q4 | 326.57 Thousand AUD | 0.0% |
2022 FY | 326.57 Thousand AUD | 11.64% |
2022 Q2 | 121.97 Thousand AUD | 0.0% |
2021 FY | 292.53 Thousand AUD | -63.33% |
2021 Q4 | 292.53 Thousand AUD | 0.0% |
2021 Q2 | 582.7 Thousand AUD | 0.0% |
2020 FY | 797.69 Thousand AUD | 46.54% |
2020 Q4 | 797.69 Thousand AUD | 0.0% |
2020 Q2 | 595.69 Thousand AUD | 0.0% |
2019 Q4 | 544.34 Thousand AUD | 0.0% |
2019 FY | 544.34 Thousand AUD | 9.33% |
2019 Q2 | 530.49 Thousand AUD | 0.0% |
2018 Q4 | 497.9 Thousand AUD | 0.0% |
2018 FY | 497.9 Thousand AUD | -78.69% |
2018 Q2 | 2.26 Million AUD | 0.0% |
2017 Q4 | 2.33 Million AUD | 0.0% |
2017 FY | 2.33 Million AUD | 13.62% |
2017 Q2 | 1.75 Million AUD | 0.0% |
2016 FY | 2.05 Million AUD | 79.37% |
2016 Q2 | 1.43 Million AUD | 0.0% |
2016 Q4 | 2.05 Million AUD | 0.0% |
2015 Q4 | 1.14 Million AUD | 0.0% |
2015 Q2 | 518.68 Thousand AUD | 0.0% |
2015 FY | 1.14 Million AUD | 102.54% |
2014 FY | 565.95 Thousand AUD | 94.02% |
2014 Q4 | 565.95 Thousand AUD | 0.0% |
2014 Q2 | 219.07 Thousand AUD | 0.0% |
2013 Q4 | 291.69 Thousand AUD | 0.0% |
2013 FY | 291.69 Thousand AUD | 36.05% |
2013 Q3 | 291.69 Thousand AUD | -7.21% |
2013 Q2 | 314.35 Thousand AUD | 0.0% |
2013 Q1 | 314.35 Thousand AUD | 46.62% |
2012 Q4 | 214.4 Thousand AUD | 0.0% |
2012 FY | 214.4 Thousand AUD | -26.3% |
2011 Q4 | 290.9 Thousand AUD | 0.0% |
2011 FY | 290.9 Thousand AUD | 1189.05% |
2010 Q4 | 22.56 Thousand AUD | 0.0% |
2010 FY | 22.56 Thousand AUD | -76.58% |
2009 FY | 96.37 Thousand AUD | -40.24% |
2009 Q4 | 96.37 Thousand AUD | 0.0% |
2008 FY | 161.26 Thousand AUD | -80.43% |
2008 Q4 | 161.26 Thousand AUD | 0.0% |
2007 Q4 | 824.04 Thousand AUD | 0.0% |
2007 FY | 824.04 Thousand AUD | -48.16% |
2006 Q4 | 1.58 Million AUD | 0.0% |
2006 FY | 1.58 Million AUD | 23.33% |
2005 FY | 1.28 Million AUD | 60.66% |
2005 Q4 | 1.28 Million AUD | 0.0% |
2004 Q4 | 802.3 Thousand AUD | 0.0% |
2004 FY | 802.3 Thousand AUD | 0.0% |
2002 Q4 | 429.25 Thousand AUD | 0.0% |
2002 FY | 429 Thousand AUD | 36.19% |
2001 Q4 | 314.79 Thousand AUD | 0.0% |
2001 FY | 315 Thousand AUD | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
AdAlta Limited | -1.67 Million AUD | 194.349% |
Biome Australia Limited | 1.88 Million AUD | 16.095% |
Radiopharm Theranostics Limited | -987.41 Thousand AUD | 260.481% |
Biotron Limited | - AUD | -Infinity% |
Acrux Limited | 147 Thousand AUD | -977.965% |
Alterity Therapeutics Limited | 1.00 AUD | -158460700.0% |
Botanix Pharmaceuticals Limited | 1.2 Million AUD | -31.027% |
BTC Health Limited | - AUD | -Infinity% |
Chimeric Therapeutics Limited | - AUD | -Infinity% |
CSL Limited | 8.93 Billion AUD | 99.982% |
Clarity Pharmaceuticals Ltd | - AUD | -Infinity% |
Clinuvel Pharmaceuticals Limited | 10.62 Million AUD | 85.088% |
Immutep Limited | 2.00 AUD | -79230300.0% |
Memphasys Limited | 164.76 Thousand AUD | -861.762% |
Neuren Pharmaceuticals Limited | - AUD | -Infinity% |
Noxopharm Limited | -2.35 Million AUD | 167.166% |
Prescient Therapeutics Limited | - AUD | -Infinity% |
Race Oncology Limited | 16.4 Thousand AUD | -9561.655% |
Starpharma Holdings Limited | 2.4 Million AUD | 34.194% |
Tissue Repair Ltd | 214.72 Thousand AUD | -637.981% |
EZZ Life Science Holdings Limited | 1.4 Million AUD | -13.09% |
Anatara Lifesciences Ltd | -671.09 Thousand AUD | 336.124% |
Bio-Gene Technology Limited | - AUD | -Infinity% |
Zelira Therapeutics Limited | 1.25 Million AUD | -26.535% |
Patrys Limited | - AUD | -Infinity% |
Orthocell Limited | 1.17 Million AUD | -34.673% |
Imugene Limited | - AUD | -Infinity% |
PYC Therapeutics Limited | -17.99 Million AUD | 108.805% |
Proteomics International Laboratories Limited | - AUD | -Infinity% |
Cynata Therapeutics Limited | 108.2 Thousand AUD | -1364.463% |
Arovella Therapeutics Limited | - AUD | -Infinity% |
Nanollose Limited | - AUD | -Infinity% |
Invex Therapeutics Ltd | -94.98 Thousand AUD | 1768.307% |
NeuroScientific Biopharmaceuticals Limited | - AUD | -Infinity% |
Amplia Therapeutics Limited | - AUD | -Infinity% |
Island Pharmaceuticals Limited | -877.24 Thousand AUD | 280.636% |
Nyrada Inc. | - AUD | -Infinity% |
Telix Pharmaceuticals Limited | 17.31 Million AUD | 90.846% |
Dimerix Limited | - AUD | -Infinity% |
PharmAust Limited | - AUD | -Infinity% |
Hexima Limited | - AUD | -Infinity% |
AnteoTech Limited | 221.85 Thousand AUD | -614.247% |
Paradigm Biopharmaceuticals Limited | - AUD | -Infinity% |
Recce Pharmaceuticals Ltd | - AUD | -Infinity% |
Avecho Biotechnology Limited | 97.11 Thousand AUD | -1531.648% |
Actinogen Medical Limited | 108.82 Thousand AUD | -1356.053% |
Argenica Therapeutics Limited | - AUD | -Infinity% |